We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Society for Clinical Trials (SCT) is an educational, charitable, and scientific organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing all clinical trial professionals.
This week the SCT 2025 Class of Fellows was announced and one of OCTRUs current interim directors - Professor Jonathan Cook was listed in that Class - A great accolade.
Jonathan will be presented with his award during the SCT 2025 Annual Meeting in Vancouver in May.
SCT has announced the 2025 Class of Fellows:
Dikla Blumberg, PhD
Rho, Inc.
Durham, North Carolina
Jonathan Cook, PhD, BSc
University of Oxford
Oxford, United Kingdom
Emily V. Dressler, PhD
Wake Forest University
School of Medicine
Winston Salem, North Carolina
Ted Lystig, PhD
BridgeBio
Huntsville, Utah
Larisa Tereshchenko, MD, PhD
Cleveland Clinic
Cleveland, Ohio
Wenle Zhao, PhD
Medical University of South Carolina
Charleston, South Carolina
These individuals will receive their awards during SCT's 2025 Annual Meeting, May 18-21.
Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.
Professor Laura Coates has been appointed Director of the Oxford Clinical Trials Research Unit (OCTRU), where she will lead the next phase of its development and strengthen its position as a leading clinical trials unit.
Professor of Orthopaedic Trauma Matthew Costa and NIHR Doctoral Research Fellow Rachel Kuo were announced among the winners of the NIHR20 Research Leaders Prizes in recognition of their outstanding contribution to health and care research.
The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.
